DK161092C - Antibiotisk stof, fremgangsmaade til fremstilling deraf, farmaceutisk praeparat indeholdende det og mikroorganismestamme til brug ved fremstilling af det - Google Patents

Antibiotisk stof, fremgangsmaade til fremstilling deraf, farmaceutisk praeparat indeholdende det og mikroorganismestamme til brug ved fremstilling af det

Info

Publication number
DK161092C
DK161092C DK457385A DK457385A DK161092C DK 161092 C DK161092 C DK 161092C DK 457385 A DK457385 A DK 457385A DK 457385 A DK457385 A DK 457385A DK 161092 C DK161092 C DK 161092C
Authority
DK
Denmark
Prior art keywords
antibiotic
factor
procedures
preparing
pharmaceutical preparation
Prior art date
Application number
DK457385A
Other languages
Danish (da)
English (en)
Other versions
DK161092B (da
DK457385A (da
DK457385D0 (da
Inventor
Enrico Selva
Luciano Gastaldo
Grazia Beretta
Angelo Borghi
Beth P Goldstein
Vittorio Arioli
Giovanni Cassani
Francesco Parenti
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of DK457385D0 publication Critical patent/DK457385D0/da
Publication of DK457385A publication Critical patent/DK457385A/da
Publication of DK161092B publication Critical patent/DK161092B/da
Application granted granted Critical
Publication of DK161092C publication Critical patent/DK161092C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P5/00—Preparation of hydrocarbons or halogenated hydrocarbons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/03—Actinomadura

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK457385A 1984-10-11 1985-10-08 Antibiotisk stof, fremgangsmaade til fremstilling deraf, farmaceutisk praeparat indeholdende det og mikroorganismestamme til brug ved fremstilling af det DK161092C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848425685A GB8425685D0 (en) 1984-10-11 1984-10-11 Antibiotic a 40926 complex
GB8425685 1984-10-11

Publications (4)

Publication Number Publication Date
DK457385D0 DK457385D0 (da) 1985-10-08
DK457385A DK457385A (da) 1986-04-12
DK161092B DK161092B (da) 1991-05-27
DK161092C true DK161092C (da) 1991-11-18

Family

ID=10568022

Family Applications (1)

Application Number Title Priority Date Filing Date
DK457385A DK161092C (da) 1984-10-11 1985-10-08 Antibiotisk stof, fremgangsmaade til fremstilling deraf, farmaceutisk praeparat indeholdende det og mikroorganismestamme til brug ved fremstilling af det

Country Status (22)

Country Link
US (1) US4935238A (2)
EP (1) EP0177882B1 (2)
JP (2) JPH0637508B2 (2)
KR (1) KR940009280B1 (2)
AT (1) ATE49215T1 (2)
AU (1) AU599308B2 (2)
CA (1) CA1317900C (2)
DE (1) DE3575145D1 (2)
DK (1) DK161092C (2)
ES (1) ES8609352A1 (2)
FI (1) FI81117C (2)
GB (1) GB8425685D0 (2)
GR (1) GR852442B (2)
HU (1) HU194317B (2)
IE (1) IE58708B1 (2)
IL (1) IL76596A (2)
MY (1) MY100880A (2)
NO (1) NO164111C (2)
NZ (1) NZ213775A (2)
PH (1) PH23013A (2)
PT (1) PT81288B (2)
ZA (1) ZA857697B (2)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8531846D0 (en) * 1985-12-30 1986-02-05 Lepetit Spa Antibiotic a 40926 mannosyl aglycon
GB8608798D0 (en) * 1986-04-11 1986-05-14 Lepetit Spa Recovery of glycopeptide antibiotics from aqueous solutions
GB8608809D0 (en) * 1986-04-11 1986-05-14 Lepetit Spa Antibiotic
DK363587A (da) * 1986-07-30 1988-01-31 Smithkline Beckman Corp Antibiotika og fremstilling heraf under anvendelseaf actinomadura parvosata
GB8621912D0 (en) * 1986-09-11 1986-10-15 Lepetit Spa Increasing ratio of components of anti-biotic complex
GR871488B (en) * 1986-10-10 1987-11-12 Lepetit Spa New antibiotics
US5135857A (en) * 1987-07-03 1992-08-04 Gruppo Lepetit S.P.A. Process for the preparation of de-mannosyl teicoplanin derivatives
PH27266A (en) * 1989-03-14 1993-05-04 Fujisawa Pharmaceutical Co WS7622, A,B,C and D substances and pharmaceutical composition containing same
WO1992010516A1 (en) * 1990-12-05 1992-06-25 Gruppo Lepetit S.P.A. 38-decarboxy-38-hydroxymethyl derivatives of teicoplanin antibiotics, and a process for preparing them
JP3314930B2 (ja) 1991-03-27 2002-08-19 バイオサーチ・イタリア・ソチエタ・ペル・アチオニ 抗生物質ａ４０９２６エステル誘導体
US5606036A (en) * 1991-03-27 1997-02-25 Gruppo Lepetit Spa Antibiotic A 40926 ester derivatives
US5750509A (en) * 1991-07-29 1998-05-12 Gruppo Lepetit S.P.A. Amide derivatives of antibiotic A 40926
DE69633234T2 (de) * 1995-07-05 2005-09-15 Aventis Bulk S.P.A. Reinigung von dalbeheptide-antibiotika mittels isoelektrofokussierung
KR20000010589A (ko) 1996-04-23 2000-02-15 클라우디오 쿼르타 항생제a40926의아미드유도체의개선된화학적제조방법
RU2124895C1 (ru) * 1998-05-28 1999-01-20 Головкина Любовь Павловна Противопаразитарная мазь "авермектиновая"
EP1413626A1 (en) * 2002-10-23 2004-04-28 Vicuron Pharmaceuticals, Inc. Genes and proteins for the biosynthesis of the glycopeptide antibiotic A40926
US20060074014A1 (en) 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
US7119061B2 (en) 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
AU2003299561A1 (en) * 2002-11-18 2004-06-15 Vicuron Pharmaceuticals Inc. Compositions and methods for treating bacterial infections with protein-dalbavancin complexes
CN110183519B (zh) * 2019-05-06 2023-04-11 大邦(湖南)生物制药有限公司 一种达巴万星关键中间体a40926的分离纯化方法
CN110156876A (zh) * 2019-05-25 2019-08-23 聊城大学 一种适合工业化生产的高纯度a40926b0制备方法
MX2021015087A (es) * 2019-06-13 2022-01-18 Regeneron Pharma Metodos para eliminar componentes no deseados durante procesos cromatograficos de multiples etapas.
CN110940763B (zh) * 2019-12-19 2022-07-26 宜昌东阳光生化制药有限公司 分离纯化达巴万星前体a40926的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195079A (en) * 1979-01-31 1980-03-25 Pfizer Inc. New polycyclic ether antibiotic
CA1183789A (en) * 1981-08-04 1985-03-12 Kiyoshi Isono Antibiotic 76-11, process for the production thereof, anticoccidiosis agent and domestic animals growth accelerator comprising the same as an effective ingredient
US4578271A (en) * 1982-05-24 1986-03-25 Fujisawa Pharmaceutical Co., Ltd. Biologically active WS 6049 substances, a process for the production thereof and their pharmaceutical compositions
GR78648B (2) * 1982-07-26 1984-09-27 Bristol Myers Co

Also Published As

Publication number Publication date
FI81117B (fi) 1990-05-31
AU4819585A (en) 1986-04-17
EP0177882A3 (en) 1987-05-27
JPH0637508B2 (ja) 1994-05-18
EP0177882B1 (en) 1990-01-03
AU599308B2 (en) 1990-07-19
ES547766A0 (es) 1986-09-01
DK161092B (da) 1991-05-27
IL76596A (en) 1992-05-25
JPS61148188A (ja) 1986-07-05
NO164111B (no) 1990-05-21
CA1317900C (en) 1993-05-18
US4935238A (en) 1990-06-19
DK457385A (da) 1986-04-12
MY100880A (en) 1991-05-16
PT81288B (pt) 1987-10-20
GB8425685D0 (en) 1984-11-14
IE58708B1 (en) 1993-11-03
NO164111C (no) 1990-08-29
DE3575145D1 (de) 1990-02-08
HU194317B (en) 1988-01-28
ZA857697B (en) 1986-07-30
IE852489L (en) 1986-04-11
DK457385D0 (da) 1985-10-08
FI81117C (fi) 1990-09-10
HUT39480A (en) 1986-09-29
NO854018L (no) 1986-04-14
ES8609352A1 (es) 1986-09-01
FI853914L (fi) 1986-04-12
JP2572937B2 (ja) 1997-01-16
KR860003342A (ko) 1986-05-23
PH23013A (en) 1989-03-03
ATE49215T1 (de) 1990-01-15
PT81288A (en) 1985-11-01
KR940009280B1 (ko) 1994-10-06
FI853914A0 (fi) 1985-10-08
GR852442B (2) 1986-02-03
EP0177882A2 (en) 1986-04-16
NZ213775A (en) 1989-03-29
JPH06225757A (ja) 1994-08-16
IL76596A0 (en) 1986-02-28

Similar Documents

Publication Publication Date Title
DK161092C (da) Antibiotisk stof, fremgangsmaade til fremstilling deraf, farmaceutisk praeparat indeholdende det og mikroorganismestamme til brug ved fremstilling af det
FR12C0065I1 (2)
DK161150C (da) Antibiotikum sb 22484, fremgangsmaade til fremstilling deraf og mikroorganisme til brug ved fremgangsmaaden
ES8103166A1 (es) Un procedimiento para producir un nuevo antibiotico.
ATE17582T1 (de) Antibiotikum s/433, verfahren zu dessen herstellung und dessen verwendung als antitumor- mittel.
ES479116A1 (es) Procedimiento para la obtencion de una mezcla de antibioti- cos bm782 alfaii, bm782 alfa 2 y bm782 alfa ia.
JPS5462393A (en) Preparation of antibiotic substance, verdamicin

Legal Events

Date Code Title Description
PUP Patent expired